Shingles Vaccine Bonus: Reduced Risk of Stroke?
Title: Shingles Vaccine Bonus: Reduced Risk of Stroke?Category: Health NewsCreated: 2/12/2020 12:00:00 AMLast Editorial Review: 2/13/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 13, 2020 Category: Cardiology Source Type: news

Shingles Vaccine Bonus: Reduced Risk of Stroke?
Overall stroke risk dropped 20% among patients under age 80 who got the shingles vaccine. In patients 80 and older, risk was cut by about 10%, said researchers. (Source: WebMD Health)
Source: WebMD Health - February 12, 2020 Category: Consumer Health News Source Type: news

Uptake of shingles vaccination is more likely if proactively offered in primary care
The shingles vaccination programme is intended for people aged between 70 and 80 years, but uptake in this group has been low. This survey found that people were more likely to have had the vaccine if it was proactively offered by a GP or nurse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 12, 2020 Category: Consumer Health News Source Type: news

Shingles Vaccine Bonus: Reduced Risk of Stroke?
WEDNESDAY, Feb. 12, 2020 -- Seniors who get the shingles vaccine may gain stroke protection as well, a new study suggests. Shingles is a viral infection tied to heightened risk of stroke. But overall stroke risk dropped 20% among patients under age... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 12, 2020 Category: General Medicine Source Type: news

ASA: Herpes Zoster Vaccine May Reduce Risk for Stroke
WEDNESDAY, Feb. 12, 2020 -- Vaccination with zoster vaccine live (ZVL) is associated with a reduced risk for stroke among older adults, according to a study to be presented at the American Stroke Association International Stroke Conference, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news

Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data
Study of 9604 adults with both household exposure to varicella and an episode of zoster found that exposure to varicella is linked to reduction in risk of zoster by ~30% over 20 years, though findings cannot be used to justify for or against specific vaccination schedules. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 24, 2020 Category: Consumer Health News Source Type: news

Exposure to chickenpox as adult does not fully protect against shingles
Adults re-exposed to the herpes zoster virus found to be around 30% less likely to develop shingles Related items fromOnMedica GPs are dealing with growing flu rates Experts predict 'invigorated' winter flu Illness poorly managed in those with learning disability Flu activity appears to be nearing its peak Doctors can help overcome ‘vaccine hesitancy’ (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 23, 2020 Category: UK Health Source Type: news

UTHSC College of Pharmacy partnering with Kroger Health Nationwide
(University of Tennessee Health Science Center) The College of Pharmacy at the University of Tennessee Health Science Center has partnered with Kroger Health, the healthcare arm of The Kroger Co., on a nationwide, randomized controlled study across more than 2,200 community pharmacy locations to improve second-dose vaccination completion rates for the shingles vaccine. Elements of the project are funded through a grant from GlaxoSmithKline. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2020 Category: International Medicine & Public Health Source Type: news

Herpes zoster (shingles) immunisation programme 2018 to 2019: evaluation reports
These reports provide an evaluation of the shingles vaccination programme in England from 2018 to 2019. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 9, 2020 Category: Consumer Health News Source Type: news

Herpes zoster vaccine reduces chances of shingles after stem cell transplants
This NIHR Signal says that the risk of shingles is about 10% per year in adults after autologous stem cell transplant. The evidence summary indicates that two doses of deactivated herpes zoster vaccine could be a safe and effective way to reduce that risk by about two thirds.This effect is similar to another, heat-treated, non-live vaccine. Either vaccine could reduce the pain and need for medical treatment associated with shingles, and long-lasting complications such as post-herpetic neuralgia. It's not yet known if people need to continue taking acyclovir as well. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 20, 2019 Category: Consumer Health News Source Type: news

New Shingles Vaccine: What You Need to Know New Shingles Vaccine: What You Need to Know
The shingles vaccine Shingrix was approved in 2017. Doctors say they are learning more about how it works, its safety risks, and how it compares to Zostavax.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 15, 2019 Category: Infectious Diseases Tags: Family Medicine/Primary Care News Source Type: news

GSK sees breakthrough in shingles vaccine output in 2024
GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but a new bioreactor facility would then be ready to bring a step change in production. (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

GSK raises outlook again amid strong demand for shingles drug
UK drugmaker also boosted by performance of consumer health and vaccines divisions (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 30, 2019 Category: Pharmaceuticals Source Type: news

Medical News Today: What side effects can the shingles vaccine cause?
The shingles vaccine is effective, but it can cause side effects. Learn about the possible mild, serious, and long term side effects here. Also, learn who may benefit the most from the vaccine and who should avoid it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 15, 2019 Category: Consumer Health News Tags: Shingles Source Type: news

Shingrix for Herpes Zoster: A Review Shingrix for Herpes Zoster: A Review
This brief primer reviews the pathophysiology of herpes zoster, and summarizes the results of the clinical trials of Shingrex, the newly approved recombinant vaccine for HZ prevention.Skin Therapy Letter (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 14, 2019 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news

Shingles Vaccine Not the Only Immunization Linked With Gout Flare Shingles Vaccine Not the Only Immunization Linked With Gout Flare
The recombinant shingles vaccine (RZV) is associated with an increased risk of gout flare, and a new study suggests other vaccines may trigger flares as well, researchers say.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 21, 2019 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

I thought the rashes were insect bites. I actually had shingles, and it was horrible.
Too late for the vaccine to prevent the painful nerve condition, I had to focus on long-term treatment. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 3, 2019 Category: Consumer Health News Authors: Christine Lehmann Source Type: news

GSK lifts outlook after vaccines drive strong quarter
Shingles and meningitis treatments help offset blow from generic version of key drug (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 24, 2019 Category: Pharmaceuticals Source Type: news

Can A Vaccine Help Reduce Herpes Zoster After ASCT?
Researchers looked at whether or not a two-dose recombinant zoster vaccine would reduce the incidence of herpes zoster in patients with  hematologic malignancies after autologous stem cell transplantation. (Source: CancerNetwork)
Source: CancerNetwork - July 16, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Shingrix shortage: Advice for physicians
With demand for the newer shingles vaccine, known as Shingrix, far outstripping the pace at which the manufacturer can supply it, shortages will likely continue throughout 2019, predicts the CDC.   “GlaxoSmithKline [GSK] are running their vaccine plants as much as they can, to produce more but it’s just not enough,” says Julio Viola, PharmD, the director of centralized pharmacy services at Northwell Health Systems, which operate in the New York metro area.  (Source: ConsultantLive)
Source: ConsultantLive - July 11, 2019 Category: Internal Medicine Authors: Milly Dawson Tags: Medical News Source Type: news

Two - Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
Incidence of herpes zoster decreased during median 21 - month follow - up after autologous HSCT (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 10, 2019 Category: Cancer & Oncology Tags: Infections, Oncology, Pharmacy, Journal, Source Type: news

Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
WEDNESDAY, July 10, 2019 -- A two-dose course of recombinant zoster vaccine is associated with a reduction in the incidence of herpes zoster among adults who have undergone autologous hematopoietic stem cell transplantation (HSCT), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2019 Category: Pharmaceuticals Source Type: news

Shingles vaccine safely prevents outbreaks among stem cell transplant patients
(Duke University Medical Center) A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA. The vaccine appears to offer protection from one of the most common and painful side effects of cell therapy and shows promise for patients with immune-compromising conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2019 Category: International Medicine & Public Health Source Type: news

Shingrix cost  effective versus Zostavax in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2019 Category: Drugs & Pharmacology Source Type: news

Chickenpox vaccine may reduce risk of shingles for kids
Children who have been vaccinated for chickenpox have a 78 percent lower risk of developing shingles than unvaccinated children, according to research. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 10, 2019 Category: Consumer Health News Source Type: news

Chickenpox Vaccine Shields Against Shingles Too
Kids who were vaccinated against chickenpox had a 78% lower risk of developing shingles, the researchers said. (Source: WebMD Health)
Source: WebMD Health - June 10, 2019 Category: Consumer Health News Source Type: news

2003 to 2014 Saw Incidence of Herpes Zoster Drop in Children
MONDAY, June 10, 2019 -- From 2003 to 2014, there was a decrease in herpes zoster (HZ) incidence among children, with lower incidence rates for varicella-vaccinated versus unvaccinated children, according to a study published online June 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Chickenpox Vaccine Shields Kids From Shingles, Too
MONDAY, June 10, 2019 -- Shingles isn't usually considered a kids'disease, but children can get this painful condition. Fortunately, the chickenpox vaccine can also protect them against it, a new study finds. " The virus that causes chickenpox also... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 10, 2019 Category: General Medicine Source Type: news

Chickenpox Vaccine Shields Kids From Shingles, Too
Title: Chickenpox Vaccine Shields Kids From Shingles, TooCategory: Health NewsCreated: 6/10/2019 12:00:00 AMLast Editorial Review: 6/10/2019 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - June 10, 2019 Category: Pediatrics Source Type: news

Chickenpox Vaccine May Protect Against Shingles Years Later
Children vaccinated against chickenpox had a 78 percent lower rate of shingles than their unvaccinated peers. (Source: NYT Health)
Source: NYT Health - June 10, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Shingles (Disease) Chicken Pox Vaccination and Immunization Source Type: news

GSK's shingles vaccine approved for use in China in adults aged 50 and above
GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above. (Source: Reuters: Health)
Source: Reuters: Health - May 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

What Older Adults Need To Know About Measles And Shingles Vaccines
Here's what you need to know about vaccinations for measles and shingles, which can be serious for older adults. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 22, 2019 Category: Pharmaceuticals Authors: Next Avenue, Contributor Source Type: news

Mayo Clinic Minute: What are eye shingles?
Shingles is caused by the varicella-zoster virus -- the same virus that causes chickenpox. If you've had chickenpox, the virus can lie dormant in your body's nerve tissue for years when suddenly it's triggered by stress or a weakened immune system, and manifests as shingles. A new shingles vaccine called Shingrix is recommended for anyone [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 15, 2019 Category: Databases & Libraries Source Type: news

Zostavax (Zoster Vaccine Live) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 18, 2019 Category: Drugs & Pharmacology Source Type: news

Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax)
Title: Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax)Category: MedicationsCreated: 11/9/2010 12:00:00 AMLast Editorial Review: 3/13/2019 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 13, 2019 Category: Dermatology Source Type: news

Shingles vaccine: Mayo Clinic Radio Health Minute
Shingles is a viral infection that causes a painful blistery rash. According to the?Centers for Disease Control and Prevention,?almost 1 out of every 3 people in the U.S. will develop?shingles?in their lifetime. And the risk goes up with age.? In this Mayo Clinic Radio Radio Health Minute,?Dr. Pritish Tosh, an infectious diseases specialist at Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 5, 2019 Category: Databases & Libraries Source Type: news

Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk
The higher risk for stroke with herpes zoster was not attenuated by antivirals or Zostavax vaccination in older patients, but that shouldn't slow vaccination rates or further study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Update: Common Shingrix Reactions--Which Can Be Prevented? Update: Common Shingrix Reactions--Which Can Be Prevented?
If administered incorrectly, Shingrix can produce some painful local reactions. Make sure your staff knows the differences between the two herpes zoster vaccines.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2019 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Shingles vaccine side effects mostly mild, yet 3% of complaints were serious, CDC says
Reported side effects of the Shringrix shingles vaccine in its first eight months of doctors' office use were mostly unremarkable, but 3% of the complaints were serious, according to a Thursday report from the US Centers for Disease Control and Prevention. (Source: CNN.com - Health)
Source: CNN.com - Health - January 31, 2019 Category: Consumer Health News Source Type: news

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018
Early recombinant zoster vaccine safety monitoring findings are consistent with prelicensure clinical trial data. Serious adverse events were rare, and no unexpected patterns were detected. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 31, 2019 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Vaccine Safety Source Type: news

Treating shingles after it appears doesn't reduce increased stroke risk
(American Heart Association) Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2019 Category: International Medicine & Public Health Source Type: news

Herpes zoster infection
This review covers who is at risk, typical presentation, complications, infectiousness, when to prescribe antivirals and which antiviral, when to refer, use of analgesia, latest vaccine recommendations and the difference between Zostavax and Shingrix. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2019 Category: Consumer Health News Source Type: news

More Shingles Vaccine On the Way, Maker Says
More doses of Shingrix, the shingles vaccine that has been in very short supply, are on the way to U.S. pharmacies, says drugmaker GlaxoSmithKline. However, demand may still outpace supply. (Source: WebMD Health)
Source: WebMD Health - January 10, 2019 Category: Consumer Health News Source Type: news

Cancer Patients May Face Greater Risk of Shingles
WEDNESDAY, Jan. 9, 2019 -- Newly diagnosed cancer patients may be at increased risk for the painful skin condition shingles, a new study finds. Experts say development of new vaccines might help prevent shingles in cancer patients. The study, of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2019 Category: General Medicine Source Type: news

Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S. Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S.
Shingles is becoming less common in both adults and children in the U.S., according to results from a database study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Higher Risk of Shingles Seen in Patients With Certain Cancers
(MedPage Today) -- Vaccine development may help with prevention of herpes zoster in this population (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 14, 2018 Category: Hematology Source Type: news

Cancer patients face higher risk for shingles, new vaccines hold promise for prevention
(Infectious Diseases Society of America) People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according to a new study in The Journal of Infectious Diseases. The findings may help guide efforts to prevent the often painful skin condition in cancer patients through the use of new vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 13, 2018 Category: International Medicine & Public Health Source Type: news

‘All I want for Christmas’ is the shingles vaccine, but it’s nearly impossible to find
Shortage of new shingles vaccine worsens as demand soars. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - December 7, 2018 Category: Consumer Health News Authors: Lena H. Sun Source Type: news

Herpes zoster (shingles) immunisation programme 2017 to 2018: evaluation report
This report evaluates the fifth year of the shingles vaccination programme in England from 2017 to 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

Chickenpox Outbreak Hits North Carolina School With High Vaccination Exemption Rate
A North Carolina school where a high concentration of families claim religious exemption from vaccines is facing the state’s worst chickenpox outbreak in more than 20 years. The chickenpox outbreak has affected 36 students at Asheville Waldorf School, health officials with Buncombe County said. The outbreak ranks as North Carolina’s largest since a chickenpox vaccine became available more than 20 years ago, the Asheville Citizen Times reports. The Asheville Waldorf School has one of the highest rates in the state of families who opt out of vaccines based on religious beliefs, according to data from North Caroli...
Source: TIME: Health - November 20, 2018 Category: Consumer Health News Authors: Mahita Gajanan Tags: Uncategorized chickenpox North Carolina onetime vaccines Source Type: news